NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Tue, 3 Mar · 17:00 IST

Neuland Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the exchange about its management's participation in upcoming non-deal roadshows (NDRs) organized by B&K Securities. The first roadshow is scheduled for March 10, 2026, in Hong Kong, followed by a two-day roadshow on March 11 and 12, 2026, in Singapore. These meetings will include both group sessions and one-on-one interactions with investors and analysts. The company has noted that the schedule and participant list are subject to change due to unforeseen circumstances.

Likely market impact

This is a routine regulatory disclosure about investor engagement activities and does not contain any material financial information. It signals the company's active outreach to institutional investors in Asian markets, but is unlikely to have any direct impact on the stock price.